Jeanne Fourie Zirkelbach

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions

Jiang Liu, Reena Philip, R. Pazdur, 2020, Clinical Cancer Research.

FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma

K. Goldberg, R. Pazdur, L. Amiri-Kordestani, 2021, Clinical Cancer Research.

FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Amy McKee, R. Pazdur, Todd R. Palmby, 2016, Clinical Cancer Research.

Use of Partial AUC (PAUC) to Evaluate Bioequivalence—A Case Study with Complex Absorption: Methylphenidate

Donald J. Schuirmann, A. Jackson, Yaning Wang, 2012, Pharmaceutical Research.

FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as single agents for first-line treatment of advanced/metastatic PD-L1 high NSCLC.

Jiang Liu, Martha Donoghue, R. Pazdur, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Use of Partial AUC (PAUC) to Evaluate Bioequivalence—A Case Study with Complex Absorption: Methylphenidate

Donald J. Schuirmann, A. Jackson, Yaning Wang, 2012, Pharmaceutical Research.

FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Jiang Liu, Reena Philip, Martha Donoghue, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 fusion or other rearrangement.

Jiang Liu, L. Fashoyin-Aje, Martha Donoghue, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients.

Jiang Liu, R. Pazdur, L. Amiri-Kordestani, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.